Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Study for online range monitoring with the interaction vertex imaging method.

Finck C, Karakaya Y, Reithinger V, Rescigno R, Baudot J, Constanzo J, Juliani D, Krimmer J, Rinaldi I, Rousseau M, Testa E, Vanstalle M, Ray C.

Phys Med Biol. 2017 Nov 21;62(24):9220-9239. doi: 10.1088/1361-6560/aa954e.

PMID:
29058685
2.

A pencil beam approach to proton computed tomography.

Rescigno R, Bopp C, Rousseau M, Brasse D.

Med Phys. 2015 Nov;42(11):6610-24. doi: 10.1118/1.4933422.

PMID:
26520752
3.

Quantitative proton imaging from multiple physics processes: a proof of concept.

Bopp C, Rescigno R, Rousseau M, Brasse D.

Phys Med Biol. 2015 Jul 7;60(13):5325-41. doi: 10.1088/0031-9155/60/13/5325. Epub 2015 Jun 25.

PMID:
26108277
4.

Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).

Picchi A, Musumeci G, Calabria P, Cresti A, Rescigno R, Aruffo A, Prati F, Limbruno U.

Am J Cardiol. 2015 May 15;115(10):1351-6. doi: 10.1016/j.amjcard.2015.02.042. Epub 2015 Feb 18.

PMID:
25772742
5.

The impact of tracking system properties on the most likely path estimation in proton CT.

Bopp C, Rescigno R, Rousseau M, Brasse D.

Phys Med Biol. 2014 Dec 7;59(23):N197-210. doi: 10.1088/0031-9155/59/23/N197. Epub 2014 Nov 4.

PMID:
25369370
6.

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.

7.

A complicated case of sarcoidosis. Neurosyphilis.

Rescigno RJ, Glatman M, Patel SN.

JAMA Ophthalmol. 2014 May;132(5):649-50. doi: 10.1001/jamaophthalmol.2014.179. No abstract available.

PMID:
24810695
8.

Endogenous endophthalmitis associated with intravenous drug abuse.

Patel SN, Rescigno RJ, Zarbin MA, Langer P, Bhagat N.

Retina. 2014 Jul;34(7):1460-5. doi: 10.1097/IAE.0000000000000084.

PMID:
24418848
9.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

10.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

11.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

12.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

13.

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

14.

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group.

Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415.

15.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29.

16.

Penetrating trauma associated with findings of multiple evanescent white dot syndrome in the second eye: coincidence or an atypical case of sympathetic ophthalmia?

Landolfi M, Bhagat N, Langer P, Rescigno R, Mirani N, Gass JD, Grigorian RA, Zarbin MA.

Retina. 2004 Aug;24(4):637-45.

PMID:
15300097
17.

Ophthalmic manifestations of immunodeficiency states.

Rescigno R, Dinowitz M.

Clin Rev Allergy Immunol. 2001 Apr;20(2):163-81. Review. No abstract available.

PMID:
11349608
18.

Ocular allergic diseases: differential diagnosis, examination techniques, and testing.

Dinowitz M, Rescigno R, Bielory L.

Clin Allergy Immunol. 2000;15:127-50. Review. No abstract available.

PMID:
10943291
19.

Bilateral red eyes in a patient infected with human immunodeficiency virus.

Bielory L, Sohn T, Rescigno R.

Ann Allergy Asthma Immunol. 1995 Apr;74(4):289-93. No abstract available.

PMID:
7719886

Supplemental Content

Loading ...
Support Center